Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus/Sirolimus vs Tacrolimus/MMF for GVHD Prophylaxis
NCT01428973Phase 2Active, not recruiting
- Sponsor
- University of Liège
- Start
- Sep 2011
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in graft-versus-host disease (GVHD), sponsored by University of Liège. Started Sep 2011; status: active, not recruiting.
02
Drugs
sirolimus
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01428973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01428973.